It has been 24 years since a pharmaceutical was last approved for posttraumatic stress disorder (PTSD). The condition is notoriously difficult to treat, with up to 40% patients finding no relief from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback